The Efficacy of Biologics for Stricturing Crohn's Diseases
Investigational drug(s) / intervention(s)
treat these patients with biologics
treat these patients with biologics: treat these patients with biologics
Study summary
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Eligibility
Sex
ALL
Min age
16 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* patients with stricturing Crohn's diseases
* no surgical indication
* patients with asymptomatic penetrating diseases
* written consent acquired
Exclusion Criteria:
* patients with surgical indication
* patients with symptomatic penetrating diseases
* contraindication of biologics
* anticipating other trial
Primary outcome measure(s)
clinical remission rate at 1 year — clinical remission rate at 1 year clinical remission rate at 1 year (CDAI less than 150)
Trial sites (1)
Facility
City
Region
Status
Department of General Surgery, Jinling hosptal,Medical School of Nanjing University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.